GNAS imprinting and pituitary tumors

Molecular and Cellular Endocrinology

Volumn 326, Issue 1-2, 2010, Pages 15-18

  Mantovani, G ^a   Lania, A G ^a   Spada, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

GH secreting pituitary adenomas; GNAS; Imprinting; Pathogenesis

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PROTEIN PRKAR1A; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADENOMA; ALBRIGHT SYNDROME; CARCINOGENESIS; CARNEY COMPLEX; DISEASE ASSOCIATION; ENZYME ACTIVATION; EPIGENETICS; GENE MUTATION; GENOME IMPRINTING; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE SECRETING ADENOMA; GROWTH HORMONE SECRETING CELL; HETEROZYGOSITY LOSS; HORMONE RELEASE; HUMAN; HYPOPHYSIS TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PSEUDOHYPOPARATHYROIDISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FIBROUS DYSPLASIA, POLYOSTOTIC; GENOMIC IMPRINTING; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MICE; PITUITARY GLAND; PITUITARY NEOPLASMS;

EID: 77955314342     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.04.009     Document Type: Review

References (44)

1. Adams E.F., Brockmeier S., Friedmann E., Roth M., Buchfelder M., Fahlbusch R. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors. Neurosurgery 1993, 33:198-203.
2. Ballaré E., Mantovani S., Lania A., Di Blasio A.M., Vallar L., Spada A. Activating mutations of the Gs alpha gene are associated with low levels of Gs alpha protein in growth hormone-secreting tumors. J. Clin. Endocrinol. Metab. 1998, 83(12):4386-4390.
3. Barlier A., Gunz G., Zamora A.J., Morange-Ramos I., Figarella-Branger D., Dufour H., Enjalbert A., Jaquet P. Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas. J. Clin. Endocrinol. Metab. 1998, 83:1604-1610.
4. Bartolomei M.S., Tilgham S.M. Genomic imprinting in mammals. Annu. Rev. Genet. 1997, 31:493-525.
5. Bastepe M., Pincus J.E., Sugimoto T., Tojo K., Kanatani M., Azuma Y., Kruse K., Rosenbloom A.L., Koshiyama H., Juppner H. Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum. Mol. Genet. 2001, 10:1231-1241.
6. Bastepe M., Gunes Y., Perez-Villamil B., Hunzelman J., Weinstein L.S., Jüppner H. Receptor-mediated adenylyl cyclase activation through XLalpha(s), the extra-large variant of the stimulatory G protein alpha-subunit. Mol. Endocrinol. 2002, 16:1912-1919.
7. Bastepe M., Juppner H. GNAS locus and pseudohypoparathyroidism. Horm. Res. 2005, 63:65-74.
8. Bastepe M., Frohlich L.F., Linglart A., Abu-Zahra H.S., Tojo K., Ward L.M., Juppner H. Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat. Genet. 2005, 37:25-27.
9. Bastepe M. The GNAS locus and pseudohypoparathyroidism. Adv. Exp. Med. Biol. 2008, 626:27-40.
10. Bertherat J., Groussin L., Sandrini F., Matyakhina L., Bei T., Stergiopoulos S., Papageorgioo T., Bourdeau I., Kirschner L.S., Vincent-Dejean C., Perlemoine K., Gicquel C., Bertagna X., Stratakis C.A. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res. 2003, 63:5308-5319.
11. Billestrup N., Swanson L.W., Vale W. Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:6854-6857.
12. Casey M., Vaughan C.J., He J., Hatcher C.J., Winter J.M., Weremowicz S., Montgomery K., Kucherlapati R., Morton C.C., Basson C.T. Mutations in the protein kinase A R1 alpha regulatory subunit cause familial myxomas and Carney complex. J. Clin. Invest. 2000, 106:R31-R38.
13. de Nanclares G.P., Fernández-Rebollo E., Santin I., García-Cuartero B., Gaztambide S., Menéndez E., Morales M.J., Pombo M., Bilbao J.R., Barros F., Zazo N., Ahrens W., Jüppner H., Hiort O., Castaño L., Bastepe M. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright hereditary osteodystrophy. J. Clin. Endocrinol. Metab. 2007, 92:2370-2373.
14. Germain-Lee E.L., Ding C.L., Deng Z., Crane J.L., Saji M., Ringel M.D., Levine M.A. Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem. Biophys. Res. Commun. 2002, 296:67-72.
15. Germain-Lee E.L., Groman J., Crane J.L., Jan de Beur S.M., Levine M.A. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J. Clin. Endocrinol. Metab. 2003, 88:4059-4069.
16. Hayward B.E., Barlier A., Korbonits M., Grossman A.B., Jacquet P., Enjalbert A., Bonthron D.T. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J. Clin. Invest. 2001, 107(6):R31-36.
17. Kaya A.I., Ugur O., Oner S.S., Bastepe M., Onaran H.O. Coupling of beta2-adrenoceptors to XLalphas and Galphas: a new insight into ligand-induced G protein activation. J. Pharmacol. Exp. Ther. 2009, 329:350-359.
18. Kirschner L.S., Carney J.A., Pack S.D., Taymans S.E., Giatzakis C., Cho Y.S., Cho-Chung Y.S., Stratakis C.A. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat. Genet. 2000, 26:89-92.
19. Klemke M., Pasolli H.A., Kehlenbach R.H., Offermanns S., Schultz G., Huttner W.B. Characterization of the extra-large G protein alpha-subunit XLalphas. II. Signal transduction properties. J. Biol. Chem. 2000, 275:33633-33640.
20. Landis C.A., Masters S.B., Spada A., Pace A.M., Bourne H.R., Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989, 340:692-696.
21. Landis C.A., Harsh G., Lyons J., Davis R.L., McCormick F., Bourne H.R. Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. J. Clin. Endocrinol. Metab. 1990, 71:1416-1420.
22. Lania A., Persani L., Ballarè E., Mantovani S., Losa M., Spada A. Constitutively active Gsa is associated with an increased phosphodiesterase activity in human growth hormone secreting adenomas. J. Clin. Endocrinol. Metab. 1998, 83:1624-1628.
23. Lania A., Mantovani G., Ferrero S., Pellegrini C., Bondioni S., Peverelli E., Braidotti P., Locatelli M., Zavanone M., Ferrante E., Bosari S., Beck-Peccoz P., Spada A. Proliferation of transformed somatotroph cells related to low or absent expression of PKA regulatory subunit 1A protein. Cancer Res. 2004, 64:9193-9198.
24. Lania A.G., Ferrero S., Pivonello R., Mantovani G., Peverelli E., Di Sarno A., Beck-Peccoz P., Spada A., Colao A. Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation. J. Clin. Endocrinol. Metab. 2010, Epub 2009 Nov 4. PubMed PMID: 19890024.
25. Linglart A., Gensure R.C., Olney R.C., Juppner H., Bastepe M. A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am. J. Hum. Genet. 2005, 76:804-814.
26. sα is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J. Clin. Endocrinol. Metab. 2003, 88:4336-4341.
27. Mantovani G., Ballare E., Giammona E., Beck-Peccoz P., Spada A. The Gsα gene: predominant maternal origin of transcription in human thyroid gland and gonads. J. Clin. Endocrinol. Metab. 2002, 87:4736-4740.
28. Mantovani G., Maghnie M., Weber G., De Menis E., Brunelli V., Cappa M., Loli P., Beck-Peccoz P., Spada A. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs alpha gene. J. Clin. Endocrinol. Metab. 2003, 88:4070-4074.
29. Mantovani G., Bondioni S., Locatelli M., Pedroni C., Lania A.G., Ferrante E., Filopanti M., Beck-Peccoz P., Spada A. Biallelic expression of the Gsalpha gene in human bone and adipose tissue. J. Clin. Endocrinol. Metab. 2004, 89:6316-6319.
30. Mantovani G., Bondioni S., Lania A.G., Corbetta S., de Sanctis L., Cappa M., Di Battista E., Chanson P., Beck-Peccoz P., Spada A. Parental origin of Gsα mutations in the McCune-Albright syndrome and in isolated endocrine tumors. J. Clin. Endocrinol. Metab. 2004, 89:3007-3009.
31. Mantovani G., Spada A. Mutations in the Gs alpha gene causing hormone resistance. Best Pract. Res. Clin. Endocrinol. Metab. 2006, 20:501-513.
32. Mantovani G., Bondioni S., Linglart A., Maghnie M., Cisternino M., Corbetta S., Lania A.G., Beck-Peccoz P., Spada A. Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib. J. Clin. Endocrinol. Metab. 2007, 92:3738-3742.
33. Mantovani G., de Sanctis L., Barbieri A.M., Elli F.M., Bollati V., Vaira V., Labarile P., Bondioni S., Peverelli E., Lania A.G., Beck-Peccoz P., Spada A. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of Albright hereditary osteodystrophy and molecular analysis in 40 patients. J. Clin. Endocrinol. Metab. 2010, 95:651-658.
34. Mariot V., Maupetit-Méhouas S., Sinding C., Kottler M.L., Linglart A. A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. J. Clin. Endocrinol. Metab. 2008, 93:661-665.
35. Mayo K.E., Miller T., DeAlmeida V., Godfrey P., Zheng J., Cunha S.R. Regulation of the pituitary somatotroph cell by GHRH and its receptor. Recent Prog. Horm. Res. 2000, 55:237-266.
36. Pasolli H.A., Klemke M., Kehlenbach R.H., Wang Y., Huttner W.B. Characterization of the extra-large G protein alpha-subunit XLalphas. I. Tissue distribution and subcellular localization. J. Biol. Chem. 2000, 275:33622-33632.
37. Peri A., Conforti B., Baglioni-Peri S., Luciani P., Cioppi F., Buci L., Corbetta S., Ballare E., Serio M., Spada A. Expression of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein and inducible-cAMP early repressor genes in growth hormone-secreting pituitary adenomas with or without mutations of the Gs alpha gene. J. Clin. Endocrinol. Metab. 2001, 86:2111-2117.
38. Picard C., Silvy M., Gerard C., Buffat C., Lavaque E., Figarella-Branger D., Dufour H., Gabert J., Beckers A., Brue T., Enjalbert A., Barlier A. Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatment. Int. J. Cancer 2007, 121:1245-1252.
39. Stork P.J., Schmitt J.M. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell. Biol. 2002, 12:258-266.
40. Unluturk U., Harmanci A., Babaoglu M., Yasar U., Varli K., Bastepe M., Bayraktar M. Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. Am. J. Med. Sci. 2008, 336:84-90.
41. Vallar L., Spada A., Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 1987, 330:566-567.
42. Weinstein L.S., Shenker A., Gejman P.V., Merino M.J., Friedman E., Spiegel A.M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N. Engl. J. Med. 1991, 325:1688-1695.
43. Weinstein L.S., Yu S., Warner D.R., Liu J. Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr. Rev. 2001, 22:675-705.
44. Yin Z., Williams-Simons L., Parlow A.F., Asa S., Kirschner L.S. Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Mol. Endocrinol. 2008, 22:380-387.